| University of Milan | |
|---|---|
| Logo placeholder | |
| Location | Milan, Italy |
| Type | Public Research University |
| Founded | 1924 |
| Website | unimi.it |
| Focus Areas | Alzheimer's Disease, ALS, Parkinson's Disease, Mitochondrial Dysfunction |
| Key Centers | Center of Excellence on Neurodegenerative Diseases (DiSFeB) Dino Ferrari Center Dept. Pathophysiology and Transplantation |
University Of Milan is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Milan (Università degli Studi di Milano) is a leading Italian research university with a strong neurodegenerative disease research tradition. The institution hosts the Center of Excellence on Neurodegenerative Diseases within the Department of Pharmacological and Biomolecular Sciences (DiSFeB), as well as the Dino Ferrari Center in the Department of Pathophysiology and Transplantation. Together, these centers conduct research on the molecular mechanisms of [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--, [ALS[/diseases/[als[/diseases/[als[/diseases/[als--TEMP--/diseases)--FIX--, [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--, and other neurodegenerative conditions (Gagliardi et al., 2020).
Milan's research is particularly notable for work on mitochondrial dysfunction in neurodegeneration, RNA metabolism in ALS, and pharmacological approaches to neuroprotection.
Located within the Department of Pharmacological and Biomolecular Sciences, this center investigates the molecular and cellular mechanisms of protein misfolding, neuroinflammation, and synaptic dysfunction in neurodegenerative diseases. Research programs span drug discovery, pharmacology, and cellular neuroscience applied to [Alzheimer's disease[/diseases/[alzheimers[/diseases/[alzheimers[/diseases/[alzheimers--TEMP--/diseases)--FIX--, [Parkinson's disease[/diseases/[parkinsons[/diseases/[parkinsons[/diseases/[parkinsons--TEMP--/diseases)--FIX--, and [ALS[/diseases/[als[/diseases/[als[/diseases/[als--TEMP--/diseases)--FIX-- (Cenini et al., 2019).
The Dino Ferrari Center in the Neuroscience Section of the Department of Pathophysiology and Transplantation is a clinical and research center focused on neuromuscular and neurodegenerative diseases. Key research areas include:
DiSFeB researchers investigate pharmacological strategies for neuroprotection, including modulators of neuroinflammation, autophagy enhancers, and mitochondrial-targeted therapies. The department has contributed to preclinical development of several candidate neuroprotective compounds.
Faculty at DiSFeB and the Dino Ferrari Center specialize in mitochondrial biology, RNA metabolism, pharmacology of neurodegeneration, and clinical neuromuscular diseases.
The study of University Of Milan has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.